Trial Profile
Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2015
Price :
$35
*
At a glance
- Drugs Imidafenacin (Primary) ; Fesoterodine
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors LG Life Sciences
- 18 Apr 2012 New trial record